Integral Diagnostics Stock

Integral Diagnostics EBIT

The EBIT of Integral Diagnostics (IDX.AX) as of Jul 21, 2026 is 58.29 M AUD. In the previous year, EBIT was 42.17 M AUD — a change of 38.24% (higher).

EBIT

58.29 MAUD

YoY

38.24%

Last updated:

In 2026, Integral Diagnostics's EBIT was 58.29 M AUD, a 38.24% increase from the 42.17 M AUD EBIT recorded in the previous year.

The Integral Diagnostics EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M AUD)
Date
EBIT (M AUD)
Jan 1, 2024
42.17 base
Jan 1, 2025
58.29 base
Jan 1, 2026 (e)
96.98 base
Jan 1, 2027 (e)
109.82 base
Jan 1, 2028 (e)
123.59 base
Jan 1, 2029 (e)
154.61 base
Jan 1, 2030 (e)
160.19 base
Jan 1, 2031 (e)
0.00 base
YEAREBIT (M AUD)
2031 est -
2030 est 160.19
2029 est 154.61
2028 est 123.59
2027 est 109.82
2026 est 96.98
2025 58.29
2024 42.17
2023 39.83
2022 38.62
2021 56.07
2020 48.67
2019 37.87
2018 28.64
2017 23.87
2016 26.59
2015 25.11
2014 10.50
2013 10.30
Access this data via the Eulerpool API

Integral Diagnostics Revenue

Integral Diagnostics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
469.70 M AUD
42.17 M AUD
-60.70 M AUD
Jan 1, 2025
627.97 M AUD
58.29 M AUD
4.67 M AUD
Jan 1, 2026 (e)
812.03 M AUD
96.98 M AUD
39.50 M AUD
Jan 1, 2027 (e)
863.18 M AUD
109.82 M AUD
47.26 M AUD
Jan 1, 2028 (e)
915.26 M AUD
123.59 M AUD
56.06 M AUD
Jan 1, 2029 (e)
946.91 M AUD
154.61 M AUD
64.20 M AUD
Jan 1, 2030 (e)
993.29 M AUD
160.19 M AUD
75.38 M AUD
Jan 1, 2031 (e)
1.06 B AUD
0.00 AUD
80.74 M AUD

Integral Diagnostics Margins

Integral Diagnostics stock margins

The Integral Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Integral Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Integral Diagnostics.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
95.12 %
8.98 %
-12.92 %
Jan 1, 2025
95.52 %
9.28 %
0.74 %
Jan 1, 2026 (e)
95.52 %
11.94 %
4.86 %
Jan 1, 2027 (e)
95.52 %
12.72 %
5.48 %
Jan 1, 2028 (e)
95.52 %
13.50 %
6.12 %
Jan 1, 2029 (e)
95.52 %
16.33 %
6.78 %
Jan 1, 2030 (e)
95.52 %
16.13 %
7.59 %
Jan 1, 2031 (e)
95.52 %
0.00 %
7.65 %

Integral Diagnostics Stock analysis

What does Integral Diagnostics do? Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Integral Diagnostics's EBIT

Integral Diagnostics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Integral Diagnostics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Integral Diagnostics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Integral Diagnostics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Integral Diagnostics stock

EBIT of Integral Diagnostics is 58.29 M AUD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Integral Diagnostics

All Key Metrics — Integral Diagnostics